eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Warner Chilcott UK Limited

1 The Heights, Brooklands, Weybridge, KT12 0NY
Telephone: +44 (0)1932 82 9600
Fax: +44 (0)1932 82 1644
WWW: http://www.wcrx.com
Medical Information Direct Line: +44 (0)800 0328 701
Medical Information e-mail: medcomukir@wcrx.com
Medical Information Fax: +44 (0)1932 824 775

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Summary of Product Characteristics last updated on the eMC: 02/09/2010
SPC Intrinsa 300 micrograms/24 hours transdermal patch

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 02/09/2010 and displayed until Current
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   15-Mar-2010
Legal Category:   POM
Black Triangle (CHM):   YES

Free-text change information supplied by the pharmaceutical company



7.       MARKETING AUTHORISATION HOLDER

 

Warner Chilcott UK Limited

Old Belfast Road

Millbrook, Larne

County Antrim

BT40 2SH

United Kingdom

Updated on 04/11/2008 and displayed until 02/09/2010
Reasons for adding or updating:
  • Change to section 6. 3 - Shelf Life
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   16-Sep-2008
Legal Category:   POM
Black Triangle (CHM):   YES

Free-text change information supplied by the pharmaceutical company

Updated section 6.3:

3 years

Updated section 10:

16/09/2008

Updated on 22/09/2008 and displayed until 04/11/2008
Reasons for adding or updating:
  • Addition of Black Triangle
Date of revision of text on the SPC:   18-Sep-2008
Legal Category:   POM
Black Triangle (CHM):   YES

Free-text change information supplied by the pharmaceutical company

Section 1:

Black triangle was accidently removed, this update is to physically add the black triangle to SPC
Updated on 08/09/2008 and displayed until 22/09/2008
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
Date of revision of text on the SPC:   23-Apr-2008
Legal Category:   POM
Black Triangle (CHM):   YES

Free-text change information supplied by the pharmaceutical company

In section 4.8 (undesirable effects), abdominal pain has been added
Updated on 29/03/2007 and displayed until 08/09/2008
Reasons for adding or updating:
  • Addition of Black Triangle
Date of revision of text on the SPC:   07/2006
Legal Category:   POM
Black Triangle (CHM):   YES

Free-text change information supplied by the pharmaceutical company

Added black triangle to section 1
Updated on 26/03/2007 and displayed until 29/03/2007
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 26/03/2007 and displayed until 26/03/2007
Reasons for adding or updating:
  • New SPC for new product

Active Ingredients/Generics

 
   testosterone